bpc-157 safety regulatory status An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with I am getting so many

I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval FDA's Review Of Peptides Signals A Growing Public Health Challenge bpc 157 human clinical trials evidence review safety regulatory status BPC157 10 mg COA verified peptide

SKU: 67302482499 · From hgidocs.co